Stephen is a member of the firm’s Antitrust & Competition practice group. He has experience with various antitrust issues, such as merger reviews, price fixing, market allocation, joint ventures, group boycotts, exclusive dealing, and monopolization. He is experienced in many aspects of antitrust litigation in federal courts, including drafting pleadings and motions, conducting expert and fact discovery, taking depositions, settlement negotiations, and trials.

Since joining the firm, Stephen has played a significant role in merger review filings, investigations, litigation, and strategic advice. He has assisted clients across various industries, including food and agriculture, healthcare, sports and entertainment, retail, financial services, and technology.

Before joining the firm, Stephen served as a Deputy Attorney General in the Pennsylvania Office of Attorney General, Antitrust Section. There, he was responsible for investigating and litigating antitrust mergers and conduct cases across a range of industries. Notable matters during this time include an action against Martin Shkreli and his company, Vyera Pharmaceuticals, alleging a scheme to block generic competition in violation of the Sherman Act and state law. Stephen was also involved in multidistrict litigation alleging an industry-wide conspiracy in the generic pharmaceutical industry and a joint action with the FTC to block the merger of two Philadelphia health systems. His antitrust experience also includes an internship with the Healthcare and Consumer Products Section of the Department of Justice, Antitrust Division.

Stephen’s work with state attorneys general, the Federal Trade Commission, and the Department of Justice provides him with a unique perspective on joint investigations and litigation among antitrust enforcers. He leverages this experience to provide practical and strategic assistance to clients.